Gain Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $679k | 384k | 1.77 |
| 2025-06-30 | $291k | 162k | 1.80 |
| 2025-03-31 | $69k | 36k | 1.91 |
| 2024-12-31 | $60k | 28k | 2.16 |
| 2024-03-31 | $47k | 12k | 3.77 |
| 2023-12-31 | $241k | 74k | 3.27 |
| 2023-09-30 | $167k | 52k | 3.23 |
| 2023-06-30 | $238k | 53k | 4.48 |
| 2023-03-31 | $146k | 30k | 4.82 |
| 2021-12-31 | $70k | 13k | 5.37 |